Lataa...
Up‐regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia
The mammalian target of rapamycin (mTOR) inhibitor, DNA damage inducible transcript 4 (DDIT4), has inducible expression in response to various cellular stresses. In multiple malignancies, studies have shown that DDIT4 participates in tumorigenesis and impacts patient survival. We aimed to study the...
Tallennettuna:
| Julkaisussa: | J Cell Mol Med |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6933361/ https://ncbi.nlm.nih.gov/pubmed/31755224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14831 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|